This poster presents the protocol for the REALITY studies within the Vitaccess Real MG Registry, investigating real-world clinical outcomes and patient experience in adults with generalised myasthenia gravis initiating zilucoplan or rozanolixizumab. The mixed-methods studies combine longitudinal quantitative outcomes with qualitative patient interviews
See here for more of our publications.





